FLUOXETINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Fluoxetine Hydrochloride patents expire, and what generic alternatives are available?
Fluoxetine Hydrochloride is a drug marketed by Barr, Dr Reddys Labs Ltd, Accord Hlthcare, Alembic Pharms Ltd, Ani Pharms, Apnar Pharma Lp, Aurobindo Pharma, Beximco Pharms Usa, Cadila Pharms Ltd, Carlsbad, Cr Double Crane, Granules, Heritage Pharms, Ivax Sub Teva Pharms, Landela Pharm, Marksans Pharma, Micro Labs, Mylan, Mylan Pharms Inc, Natco Pharma Usa, Sandoz, Sciegen Pharms Inc, Specgx Llc, Strides Pharma, Sun Pharm Inds Ltd, Teva, Teva Pharms Usa, Actavis Mid Atlantic, Akorn, Aptapharma Inc, Chartwell Molecular, Lannett Co Inc, Nostrum Labs Inc, Novitium Pharma, Pharm Assoc, Pharmobedient Cnsltg, Alembic, Aurobindo Pharma Ltd, Dr Reddys, Fosun Pharma, G And W Labs Inc, Inventia Hlthcare, Lupin Ltd, Par Form, Par Pharm Inc, Rising, Slate Run Pharma, Taro, Torrent, Twi Pharms, and Upsher Smith Labs. and is included in sixty-five NDAs.
The generic ingredient in FLUOXETINE HYDROCHLORIDE is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluoxetine Hydrochloride
A generic version of FLUOXETINE HYDROCHLORIDE was approved as fluoxetine hydrochloride by APNAR PHARMA LP on August 2nd, 2001.
Summary for FLUOXETINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 51 |
NDAs: | 65 |
Finished Product Suppliers / Packagers: | 68 |
Raw Ingredient (Bulk) Api Vendors: | 174 |
Clinical Trials: | 294 |
Patent Applications: | 4,684 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in FLUOXETINE HYDROCHLORIDE? | FLUOXETINE HYDROCHLORIDE excipients list |
DailyMed Link: | FLUOXETINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for FLUOXETINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
First Affiliated Hospital Xi'an Jiaotong University | N/A |
Chen Qian | Early Phase 1 |
Second Xiangya Hospital of Central South University | Phase 1/Phase 2 |
Pharmacology for FLUOXETINE HYDROCHLORIDE
Drug Class | Serotonin Reuptake Inhibitor |
Mechanism of Action | Serotonin Uptake Inhibitors |